Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in ...

In a new brief, the Purchaser Business Group on Health called for policy changes that address healthcare costs and improve access to high-quality care.

The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth ...

There is a dearth of professionals with licenses and training to provide care for seniors’ mental and behavioral health challenges — such as Alzheimer's and other dementias, anxiety and ...

Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them from expanding their reach. The weekly injections and ...

When I look back on my journey, I’m reminded of how much can change when you are able to ask for, and receive, help. My name is Dr. Christopher Schenewerk. I am a physician, a father, and a ...

While large-molecule therapeutics capture most headlines, small-molecule drugs face significant challenges, struggling with funding cuts, supply chain disruptions, and growing demand. At the same ...